IP Library Granted Patent US 8,183,027
Granted Patent B2
US 8,183,027 · App. 13/243,136 · Granted May 22, 2012

Methods and compositions for the recombinant biosynthesis of N-Alkanes

Assignee: Joule Unlimited Technologies, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,183,027
App. No.
13/243,136
Granted
May 22, 2012
Kind
B2
Abstract

The present disclosure identifies methods and compositions for modifying photoautotrophic organisms as hosts, such that the organisms efficiently convert carbon dioxide and light into n-alkanes, and in particular the use of such organisms for the commercial production of n-alkanes and related molecules.

Claims (18)

1. An engineered cyanobacterium, wherein said engineered cyanobacterium comprises a recombinant acyl-ACP reductase enzyme and a recombinant alkanal decarboxylative monooxygenase enzyme, wherein at least one of said recombinant enzymes is heterologous with respect to said engineered cyanobacterium; and wherein said cyanobacterium, when cultured in the presence of light and an inorganic carbon source, produces n-alkanes, wherein at least one of said n-alkanes is selected from the group consisting of n-tridecane, n-tetradecane, n-pentadecane , n-hexadecane, and n-heptadecane, and wherein the amount of said n-alkanes produced is at least 0.1% dry cell weight and at least two times the amount produced by an otherwise identical cyanobacterium, cultured under identical conditions, but lacking said recombinant acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes.

2. The engineered cyanobacterium of claim 1 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are encoded by genes which are at least 95% identical to SEQ ID NO: 10 and SEQ ID NO: 12, respectively.

3. The engineered cyanobacterium of claim 1 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are encoded by genes which are at least 95% identical to SEQ ID NO: 27 and SEQ ID NO: 29, respectively.

4. The engineered cyanobacterium of claim 1 , wherein said engineered cyanobacterium is a thermophile.

5. The engineered cyanobacterium of claim 1 , wherein said enzymes are encoded by recombinant genes incorporated into the genome of said engineered cyanobacterium.

6. The engineered cyanobacterium of claim 5 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are at least 95% identical to SEQ ID NO:10 and SEQ ID NO:12, respectively.

7. The engineered cyanobacterium of claim 6 , wherein expression of said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes is controlled by an inducible promoter.

8. The engineered cyanobacterium of claim 7 , wherein said engineered cyanobacterium further comprises a second operon encoding acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes which are at least 95% identical to SEQ ID NO: 27 and SEQ ID NO: 29, respectively.

9. The engineered cyanobacterium of claim 1 , wherein said enzymes are encoded by genes which are present in multiple copies in said engineered cyanobacterium.

10. The engineered cyanobacterium of claim 9 , wherein said enzymes are encoded by a plasmid.

11. The engineered cyanobacterium of claim 1 , wherein said acyl-ACP reductase enzyme and said alkanal decarboxylative monooxygenase enzyme are encoded by genes which are part of an operon, and wherein the expression of said genes is controlled by one or more inducible promoters.

12. The engineered cyanobacterium of claim 11 , wherein at least one promoter is a urea-repressible, nitrate-inducible promoter.

13. The engineered cyanobacterium of claim 12 , wherein said urea-repressible, nitrate-inducible promoter is P(nir07).

14. The engineered cyanobacterium of claim 1 , wherein said engineered cyanobacterium comprises at least two operons encoding distinct alkanal decarboxylative monooxygenase and acyl-ACP reductase enzymes.

15. The engineered cyanobacterium of claim 14 , wherein at least one operon encodes acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes which are at least 95% identical to SEQ ID NO: 10 and SEQ ID NO: 12, respectively.

16. The engineered cyanobacterium of claim 14 , wherein at least one operon encodes acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes which are at least 95% identical to SEQ ID NO: 27 and SEQ ID NO: 29, respectively.

17. The engineered cyanobacterium of claim 1 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are encoded by genes which are at least 95% identical to SEQ ID NO: 6 and SEQ ID NO: 8, respectively.

18. The engineered cyanobacterium of claim 5 , wherein said acyl-ACP reductase and alkanal decarboxylative monooxygenase enzymes are encoded by genes which are at least 95% identical to SEQ ID NO: 6 and SEQ ID NO: 8, respectively.

Assignments (3)
SECURITY INTEREST Recorded Jun 23, 2016
From: JOULE UNLIMITED TECHNOLOGIES, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 039140/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2011
From: REPPAS, NIKOS BASIL; RIDLEY, CHRISTIAN PERRY
To: JOULE UNLIMITED, INC.
Reel/Frame 027063/0510 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2011
From: JOULE UNLIMITED, INC.
To: JOULE UNLIMITED TECHNOLOGIES, INC.; JOULE UNLIMITED, INC.
Reel/Frame 027063/0804 →
Continuity (6)
Continuation 13098700 · May 2, 2011
Continuation 12833821 · Jul 9, 2010
Continuation In Part 12759657 · Apr 13, 2010
Provisional Application 61224463 · Jul 9, 2009
Provisional Application 61228937 · Jul 27, 2009
Related Publication 20120009656A1 · Jan 12, 2012